| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851219 | American Heart Journal | 2009 | 9 Pages |
Abstract
Dal-OUTCOMES will determine whether CETP inhibition with dalcetrapib, added to current evidence-based care, reduces cardiovascular morbidity and mortality after ACS.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gregory G. MD, PhD, Anders G. MD, PhD, Christie M. MD, Phillip J. MD, PhD, Ingar M. PhD, David MB, BS, Lawrence A. MD, Eran MD, John J.V. MD, Prediman K. MD, Jean-Claude MD, Bernard R. MD, Regina PhD, John PhD,